GAMMA Investing’s ArriVent BioPharma AVBP Stock Holding History

GAMMA Investing’s Portfolio AVBP Stock Details AVBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.1K	Buy	435 +76	+21%	+$2.24K	﹤0.01%	2992
2026 Q1	$8.28K	Buy	359 +214	+148%	+$4.83K	﹤0.01%	3173
2025 Q4	$2.92K	Buy	145 +60	+71%	+$1.25K	﹤0.01%	3493
2025 Q3	$1.57K	Sell	85 -14	-14%	-$275	﹤0.01%	3513
2025 Q2	$2.15K	Sell	99 -46	-32%	-$955	﹤0.01%	3382
2025 Q1	$2.68K	Buy	145 +75	+107%	+$1.83K	﹤0.01%	3323
2024 Q4	$1.86K	Buy	70 +45	+180%	+$1.29K	﹤0.01%	3241
2024 Q3	$588	Buy	25 +15	+150%	+$340	﹤0.01%	3368
2024 Q2	$186	Buy	+10	New	+$178	﹤0.01%	3359

Other funds holding AVBP

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return